Global mRNA Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 127

Published Date: 19 Apr 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global mRNA Flu Vaccine market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global mRNA Flu Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global mRNA Flu Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Flu Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Flu Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global mRNA Flu Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Flu Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Flu Vaccine market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, BioNTech, CureVac, Novavax, Sanofi, Inovio Pharmaceuticals, Arcturus Therapeutics Holdings, eTheRNA immunotherapies, Valneva, Vaxart, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
mRNA Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    mRNA-1010
    mRNA-1020
    mRNA-1030

Market segment by Application
    Hospital
    Clinic
    Other

Major players covered
    Moderna
    BioNTech
    CureVac
    Novavax
    Sanofi
    Inovio Pharmaceuticals
    Arcturus Therapeutics Holdings
    eTheRNA immunotherapies
    Valneva
    Vaxart
    Entos Pharmaceuticals
    Abnova Corporation
    Anima Biotech
    Sarepta Therapeutics
    iBio
    Barinthus Biotherapeutics
    Alnylam Pharmaceuticals
    Beam Therapeutics

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe mRNA Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of mRNA Flu Vaccine, with price, sales quantity, revenue, and global market share of mRNA Flu Vaccine from 2019 to 2024.
Chapter 3, the mRNA Flu Vaccine competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the mRNA Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and mRNA Flu Vaccine market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of mRNA Flu Vaccine.
Chapter 14 and 15, to describe mRNA Flu Vaccine sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global mRNA Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 mRNA-1010
        1.3.3 mRNA-1020
        1.3.4 mRNA-1030
    1.4 Market Analysis by Application
        1.4.1 Overview: Global mRNA Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Other
    1.5 Global mRNA Flu Vaccine Market Size & Forecast
        1.5.1 Global mRNA Flu Vaccine Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global mRNA Flu Vaccine Sales Quantity (2019-2030)
        1.5.3 Global mRNA Flu Vaccine Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Moderna
        2.1.1 Moderna Details
        2.1.2 Moderna Major Business
        2.1.3 Moderna mRNA Flu Vaccine Product and Services
        2.1.4 Moderna mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Moderna Recent Developments/Updates
    2.2 BioNTech
        2.2.1 BioNTech Details
        2.2.2 BioNTech Major Business
        2.2.3 BioNTech mRNA Flu Vaccine Product and Services
        2.2.4 BioNTech mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 BioNTech Recent Developments/Updates
    2.3 CureVac
        2.3.1 CureVac Details
        2.3.2 CureVac Major Business
        2.3.3 CureVac mRNA Flu Vaccine Product and Services
        2.3.4 CureVac mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 CureVac Recent Developments/Updates
    2.4 Novavax
        2.4.1 Novavax Details
        2.4.2 Novavax Major Business
        2.4.3 Novavax mRNA Flu Vaccine Product and Services
        2.4.4 Novavax mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Novavax Recent Developments/Updates
    2.5 Sanofi
        2.5.1 Sanofi Details
        2.5.2 Sanofi Major Business
        2.5.3 Sanofi mRNA Flu Vaccine Product and Services
        2.5.4 Sanofi mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Sanofi Recent Developments/Updates
    2.6 Inovio Pharmaceuticals
        2.6.1 Inovio Pharmaceuticals Details
        2.6.2 Inovio Pharmaceuticals Major Business
        2.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Product and Services
        2.6.4 Inovio Pharmaceuticals mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Inovio Pharmaceuticals Recent Developments/Updates
    2.7 Arcturus Therapeutics Holdings
        2.7.1 Arcturus Therapeutics Holdings Details
        2.7.2 Arcturus Therapeutics Holdings Major Business
        2.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product and Services
        2.7.4 Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Arcturus Therapeutics Holdings Recent Developments/Updates
    2.8 eTheRNA immunotherapies
        2.8.1 eTheRNA immunotherapies Details
        2.8.2 eTheRNA immunotherapies Major Business
        2.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Product and Services
        2.8.4 eTheRNA immunotherapies mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 eTheRNA immunotherapies Recent Developments/Updates
    2.9 Valneva
        2.9.1 Valneva Details
        2.9.2 Valneva Major Business
        2.9.3 Valneva mRNA Flu Vaccine Product and Services
        2.9.4 Valneva mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Valneva Recent Developments/Updates
    2.10 Vaxart
        2.10.1 Vaxart Details
        2.10.2 Vaxart Major Business
        2.10.3 Vaxart mRNA Flu Vaccine Product and Services
        2.10.4 Vaxart mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 Vaxart Recent Developments/Updates
    2.11 Entos Pharmaceuticals
        2.11.1 Entos Pharmaceuticals Details
        2.11.2 Entos Pharmaceuticals Major Business
        2.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Product and Services
        2.11.4 Entos Pharmaceuticals mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Entos Pharmaceuticals Recent Developments/Updates
    2.12 Abnova Corporation
        2.12.1 Abnova Corporation Details
        2.12.2 Abnova Corporation Major Business
        2.12.3 Abnova Corporation mRNA Flu Vaccine Product and Services
        2.12.4 Abnova Corporation mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 Abnova Corporation Recent Developments/Updates
    2.13 Anima Biotech
        2.13.1 Anima Biotech Details
        2.13.2 Anima Biotech Major Business
        2.13.3 Anima Biotech mRNA Flu Vaccine Product and Services
        2.13.4 Anima Biotech mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Anima Biotech Recent Developments/Updates
    2.14 Sarepta Therapeutics
        2.14.1 Sarepta Therapeutics Details
        2.14.2 Sarepta Therapeutics Major Business
        2.14.3 Sarepta Therapeutics mRNA Flu Vaccine Product and Services
        2.14.4 Sarepta Therapeutics mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.14.5 Sarepta Therapeutics Recent Developments/Updates
    2.15 iBio
        2.15.1 iBio Details
        2.15.2 iBio Major Business
        2.15.3 iBio mRNA Flu Vaccine Product and Services
        2.15.4 iBio mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.15.5 iBio Recent Developments/Updates
    2.16 Barinthus Biotherapeutics
        2.16.1 Barinthus Biotherapeutics Details
        2.16.2 Barinthus Biotherapeutics Major Business
        2.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Product and Services
        2.16.4 Barinthus Biotherapeutics mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.16.5 Barinthus Biotherapeutics Recent Developments/Updates
    2.17 Alnylam Pharmaceuticals
        2.17.1 Alnylam Pharmaceuticals Details
        2.17.2 Alnylam Pharmaceuticals Major Business
        2.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Product and Services
        2.17.4 Alnylam Pharmaceuticals mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.17.5 Alnylam Pharmaceuticals Recent Developments/Updates
    2.18 Beam Therapeutics
        2.18.1 Beam Therapeutics Details
        2.18.2 Beam Therapeutics Major Business
        2.18.3 Beam Therapeutics mRNA Flu Vaccine Product and Services
        2.18.4 Beam Therapeutics mRNA Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.18.5 Beam Therapeutics Recent Developments/Updates

3 Competitive Environment: mRNA Flu Vaccine by Manufacturer
    3.1 Global mRNA Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
    3.2 Global mRNA Flu Vaccine Revenue by Manufacturer (2019-2024)
    3.3 Global mRNA Flu Vaccine Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of mRNA Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 mRNA Flu Vaccine Manufacturer Market Share in 2023
        3.4.3 Top 6 mRNA Flu Vaccine Manufacturer Market Share in 2023
    3.5 mRNA Flu Vaccine Market: Overall Company Footprint Analysis
        3.5.1 mRNA Flu Vaccine Market: Region Footprint
        3.5.2 mRNA Flu Vaccine Market: Company Product Type Footprint
        3.5.3 mRNA Flu Vaccine Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global mRNA Flu Vaccine Market Size by Region
        4.1.1 Global mRNA Flu Vaccine Sales Quantity by Region (2019-2030)
        4.1.2 Global mRNA Flu Vaccine Consumption Value by Region (2019-2030)
        4.1.3 Global mRNA Flu Vaccine Average Price by Region (2019-2030)
    4.2 North America mRNA Flu Vaccine Consumption Value (2019-2030)
    4.3 Europe mRNA Flu Vaccine Consumption Value (2019-2030)
    4.4 Asia-Pacific mRNA Flu Vaccine Consumption Value (2019-2030)
    4.5 South America mRNA Flu Vaccine Consumption Value (2019-2030)
    4.6 Middle East & Africa mRNA Flu Vaccine Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
    5.2 Global mRNA Flu Vaccine Consumption Value by Type (2019-2030)
    5.3 Global mRNA Flu Vaccine Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
    6.2 Global mRNA Flu Vaccine Consumption Value by Application (2019-2030)
    6.3 Global mRNA Flu Vaccine Average Price by Application (2019-2030)

7 North America
    7.1 North America mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
    7.2 North America mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
    7.3 North America mRNA Flu Vaccine Market Size by Country
        7.3.1 North America mRNA Flu Vaccine Sales Quantity by Country (2019-2030)
        7.3.2 North America mRNA Flu Vaccine Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
    8.2 Europe mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
    8.3 Europe mRNA Flu Vaccine Market Size by Country
        8.3.1 Europe mRNA Flu Vaccine Sales Quantity by Country (2019-2030)
        8.3.2 Europe mRNA Flu Vaccine Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific mRNA Flu Vaccine Market Size by Region
        9.3.1 Asia-Pacific mRNA Flu Vaccine Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific mRNA Flu Vaccine Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
    10.2 South America mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
    10.3 South America mRNA Flu Vaccine Market Size by Country
        10.3.1 South America mRNA Flu Vaccine Sales Quantity by Country (2019-2030)
        10.3.2 South America mRNA Flu Vaccine Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa mRNA Flu Vaccine Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa mRNA Flu Vaccine Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa mRNA Flu Vaccine Market Size by Country
        11.3.1 Middle East & Africa mRNA Flu Vaccine Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa mRNA Flu Vaccine Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 mRNA Flu Vaccine Market Drivers
    12.2 mRNA Flu Vaccine Market Restraints
    12.3 mRNA Flu Vaccine Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of mRNA Flu Vaccine and Key Manufacturers
    13.2 Manufacturing Costs Percentage of mRNA Flu Vaccine
    13.3 mRNA Flu Vaccine Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 mRNA Flu Vaccine Typical Distributors
    14.3 mRNA Flu Vaccine Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global mRNA Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global mRNA Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Moderna Basic Information, Manufacturing Base and Competitors
 Table 4. Moderna Major Business
 Table 5. Moderna mRNA Flu Vaccine Product and Services
 Table 6. Moderna mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Moderna Recent Developments/Updates
 Table 8. BioNTech Basic Information, Manufacturing Base and Competitors
 Table 9. BioNTech Major Business
 Table 10. BioNTech mRNA Flu Vaccine Product and Services
 Table 11. BioNTech mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. BioNTech Recent Developments/Updates
 Table 13. CureVac Basic Information, Manufacturing Base and Competitors
 Table 14. CureVac Major Business
 Table 15. CureVac mRNA Flu Vaccine Product and Services
 Table 16. CureVac mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. CureVac Recent Developments/Updates
 Table 18. Novavax Basic Information, Manufacturing Base and Competitors
 Table 19. Novavax Major Business
 Table 20. Novavax mRNA Flu Vaccine Product and Services
 Table 21. Novavax mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Novavax Recent Developments/Updates
 Table 23. Sanofi Basic Information, Manufacturing Base and Competitors
 Table 24. Sanofi Major Business
 Table 25. Sanofi mRNA Flu Vaccine Product and Services
 Table 26. Sanofi mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Sanofi Recent Developments/Updates
 Table 28. Inovio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 29. Inovio Pharmaceuticals Major Business
 Table 30. Inovio Pharmaceuticals mRNA Flu Vaccine Product and Services
 Table 31. Inovio Pharmaceuticals mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Inovio Pharmaceuticals Recent Developments/Updates
 Table 33. Arcturus Therapeutics Holdings Basic Information, Manufacturing Base and Competitors
 Table 34. Arcturus Therapeutics Holdings Major Business
 Table 35. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product and Services
 Table 36. Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 37. Arcturus Therapeutics Holdings Recent Developments/Updates
 Table 38. eTheRNA immunotherapies Basic Information, Manufacturing Base and Competitors
 Table 39. eTheRNA immunotherapies Major Business
 Table 40. eTheRNA immunotherapies mRNA Flu Vaccine Product and Services
 Table 41. eTheRNA immunotherapies mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 42. eTheRNA immunotherapies Recent Developments/Updates
 Table 43. Valneva Basic Information, Manufacturing Base and Competitors
 Table 44. Valneva Major Business
 Table 45. Valneva mRNA Flu Vaccine Product and Services
 Table 46. Valneva mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 47. Valneva Recent Developments/Updates
 Table 48. Vaxart Basic Information, Manufacturing Base and Competitors
 Table 49. Vaxart Major Business
 Table 50. Vaxart mRNA Flu Vaccine Product and Services
 Table 51. Vaxart mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 52. Vaxart Recent Developments/Updates
 Table 53. Entos Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 54. Entos Pharmaceuticals Major Business
 Table 55. Entos Pharmaceuticals mRNA Flu Vaccine Product and Services
 Table 56. Entos Pharmaceuticals mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 57. Entos Pharmaceuticals Recent Developments/Updates
 Table 58. Abnova Corporation Basic Information, Manufacturing Base and Competitors
 Table 59. Abnova Corporation Major Business
 Table 60. Abnova Corporation mRNA Flu Vaccine Product and Services
 Table 61. Abnova Corporation mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 62. Abnova Corporation Recent Developments/Updates
 Table 63. Anima Biotech Basic Information, Manufacturing Base and Competitors
 Table 64. Anima Biotech Major Business
 Table 65. Anima Biotech mRNA Flu Vaccine Product and Services
 Table 66. Anima Biotech mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 67. Anima Biotech Recent Developments/Updates
 Table 68. Sarepta Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 69. Sarepta Therapeutics Major Business
 Table 70. Sarepta Therapeutics mRNA Flu Vaccine Product and Services
 Table 71. Sarepta Therapeutics mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 72. Sarepta Therapeutics Recent Developments/Updates
 Table 73. iBio Basic Information, Manufacturing Base and Competitors
 Table 74. iBio Major Business
 Table 75. iBio mRNA Flu Vaccine Product and Services
 Table 76. iBio mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 77. iBio Recent Developments/Updates
 Table 78. Barinthus Biotherapeutics Basic Information, Manufacturing Base and Competitors
 Table 79. Barinthus Biotherapeutics Major Business
 Table 80. Barinthus Biotherapeutics mRNA Flu Vaccine Product and Services
 Table 81. Barinthus Biotherapeutics mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 82. Barinthus Biotherapeutics Recent Developments/Updates
 Table 83. Alnylam Pharmaceuticals Basic Information, Manufacturing Base and Competitors
 Table 84. Alnylam Pharmaceuticals Major Business
 Table 85. Alnylam Pharmaceuticals mRNA Flu Vaccine Product and Services
 Table 86. Alnylam Pharmaceuticals mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 87. Alnylam Pharmaceuticals Recent Developments/Updates
 Table 88. Beam Therapeutics Basic Information, Manufacturing Base and Competitors
 Table 89. Beam Therapeutics Major Business
 Table 90. Beam Therapeutics mRNA Flu Vaccine Product and Services
 Table 91. Beam Therapeutics mRNA Flu Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 92. Beam Therapeutics Recent Developments/Updates
 Table 93. Global mRNA Flu Vaccine Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 94. Global mRNA Flu Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 95. Global mRNA Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 96. Market Position of Manufacturers in mRNA Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 97. Head Office and mRNA Flu Vaccine Production Site of Key Manufacturer
 Table 98. mRNA Flu Vaccine Market: Company Product Type Footprint
 Table 99. mRNA Flu Vaccine Market: Company Product Application Footprint
 Table 100. mRNA Flu Vaccine New Market Entrants and Barriers to Market Entry
 Table 101. mRNA Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
 Table 102. Global mRNA Flu Vaccine Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 103. Global mRNA Flu Vaccine Sales Quantity by Region (2019-2024) & (K Units)
 Table 104. Global mRNA Flu Vaccine Sales Quantity by Region (2025-2030) & (K Units)
 Table 105. Global mRNA Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
 Table 106. Global mRNA Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
 Table 107. Global mRNA Flu Vaccine Average Price by Region (2019-2024) & (US$/Unit)
 Table 108. Global mRNA Flu Vaccine Average Price by Region (2025-2030) & (US$/Unit)
 Table 109. Global mRNA Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 110. Global mRNA Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 111. Global mRNA Flu Vaccine Consumption Value by Type (2019-2024) & (USD Million)
 Table 112. Global mRNA Flu Vaccine Consumption Value by Type (2025-2030) & (USD Million)
 Table 113. Global mRNA Flu Vaccine Average Price by Type (2019-2024) & (US$/Unit)
 Table 114. Global mRNA Flu Vaccine Average Price by Type (2025-2030) & (US$/Unit)
 Table 115. Global mRNA Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 116. Global mRNA Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 117. Global mRNA Flu Vaccine Consumption Value by Application (2019-2024) & (USD Million)
 Table 118. Global mRNA Flu Vaccine Consumption Value by Application (2025-2030) & (USD Million)
 Table 119. Global mRNA Flu Vaccine Average Price by Application (2019-2024) & (US$/Unit)
 Table 120. Global mRNA Flu Vaccine Average Price by Application (2025-2030) & (US$/Unit)
 Table 121. North America mRNA Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 122. North America mRNA Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 123. North America mRNA Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 124. North America mRNA Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 125. North America mRNA Flu Vaccine Sales Quantity by Country (2019-2024) & (K Units)
 Table 126. North America mRNA Flu Vaccine Sales Quantity by Country (2025-2030) & (K Units)
 Table 127. North America mRNA Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 128. North America mRNA Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 129. Europe mRNA Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 130. Europe mRNA Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 131. Europe mRNA Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 132. Europe mRNA Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 133. Europe mRNA Flu Vaccine Sales Quantity by Country (2019-2024) & (K Units)
 Table 134. Europe mRNA Flu Vaccine Sales Quantity by Country (2025-2030) & (K Units)
 Table 135. Europe mRNA Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 136. Europe mRNA Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 137. Asia-Pacific mRNA Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 138. Asia-Pacific mRNA Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 139. Asia-Pacific mRNA Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 140. Asia-Pacific mRNA Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 141. Asia-Pacific mRNA Flu Vaccine Sales Quantity by Region (2019-2024) & (K Units)
 Table 142. Asia-Pacific mRNA Flu Vaccine Sales Quantity by Region (2025-2030) & (K Units)
 Table 143. Asia-Pacific mRNA Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
 Table 144. Asia-Pacific mRNA Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
 Table 145. South America mRNA Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 146. South America mRNA Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 147. South America mRNA Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 148. South America mRNA Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 149. South America mRNA Flu Vaccine Sales Quantity by Country (2019-2024) & (K Units)
 Table 150. South America mRNA Flu Vaccine Sales Quantity by Country (2025-2030) & (K Units)
 Table 151. South America mRNA Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 152. South America mRNA Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 153. Middle East & Africa mRNA Flu Vaccine Sales Quantity by Type (2019-2024) & (K Units)
 Table 154. Middle East & Africa mRNA Flu Vaccine Sales Quantity by Type (2025-2030) & (K Units)
 Table 155. Middle East & Africa mRNA Flu Vaccine Sales Quantity by Application (2019-2024) & (K Units)
 Table 156. Middle East & Africa mRNA Flu Vaccine Sales Quantity by Application (2025-2030) & (K Units)
 Table 157. Middle East & Africa mRNA Flu Vaccine Sales Quantity by Country (2019-2024) & (K Units)
 Table 158. Middle East & Africa mRNA Flu Vaccine Sales Quantity by Country (2025-2030) & (K Units)
 Table 159. Middle East & Africa mRNA Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
 Table 160. Middle East & Africa mRNA Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
 Table 161. mRNA Flu Vaccine Raw Material
 Table 162. Key Manufacturers of mRNA Flu Vaccine Raw Materials
 Table 163. mRNA Flu Vaccine Typical Distributors
 Table 164. mRNA Flu Vaccine Typical Customers


List of Figures
 Figure 1. mRNA Flu Vaccine Picture
 Figure 2. Global mRNA Flu Vaccine Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global mRNA Flu Vaccine Revenue Market Share by Type in 2023
 Figure 4. mRNA-1010 Examples
 Figure 5. mRNA-1020 Examples
 Figure 6. mRNA-1030 Examples
 Figure 7. Global mRNA Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 8. Global mRNA Flu Vaccine Revenue Market Share by Application in 2023
 Figure 9. Hospital Examples
 Figure 10. Clinic Examples
 Figure 11. Other Examples
 Figure 12. Global mRNA Flu Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 13. Global mRNA Flu Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 14. Global mRNA Flu Vaccine Sales Quantity (2019-2030) & (K Units)
 Figure 15. Global mRNA Flu Vaccine Price (2019-2030) & (US$/Unit)
 Figure 16. Global mRNA Flu Vaccine Sales Quantity Market Share by Manufacturer in 2023
 Figure 17. Global mRNA Flu Vaccine Revenue Market Share by Manufacturer in 2023
 Figure 18. Producer Shipments of mRNA Flu Vaccine by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 19. Top 3 mRNA Flu Vaccine Manufacturer (Revenue) Market Share in 2023
 Figure 20. Top 6 mRNA Flu Vaccine Manufacturer (Revenue) Market Share in 2023
 Figure 21. Global mRNA Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
 Figure 22. Global mRNA Flu Vaccine Consumption Value Market Share by Region (2019-2030)
 Figure 23. North America mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 24. Europe mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 25. Asia-Pacific mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 26. South America mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 27. Middle East & Africa mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 28. Global mRNA Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 29. Global mRNA Flu Vaccine Consumption Value Market Share by Type (2019-2030)
 Figure 30. Global mRNA Flu Vaccine Average Price by Type (2019-2030) & (US$/Unit)
 Figure 31. Global mRNA Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 32. Global mRNA Flu Vaccine Revenue Market Share by Application (2019-2030)
 Figure 33. Global mRNA Flu Vaccine Average Price by Application (2019-2030) & (US$/Unit)
 Figure 34. North America mRNA Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 35. North America mRNA Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 36. North America mRNA Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 37. North America mRNA Flu Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 38. United States mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 39. Canada mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 40. Mexico mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 41. Europe mRNA Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 42. Europe mRNA Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 43. Europe mRNA Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 44. Europe mRNA Flu Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 45. Germany mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 46. France mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 47. United Kingdom mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 48. Russia mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 49. Italy mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 50. Asia-Pacific mRNA Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 51. Asia-Pacific mRNA Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 52. Asia-Pacific mRNA Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
 Figure 53. Asia-Pacific mRNA Flu Vaccine Consumption Value Market Share by Region (2019-2030)
 Figure 54. China mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 55. Japan mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 56. South Korea mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 57. India mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 58. Southeast Asia mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 59. Australia mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 60. South America mRNA Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 61. South America mRNA Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 62. South America mRNA Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 63. South America mRNA Flu Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 64. Brazil mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 65. Argentina mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 66. Middle East & Africa mRNA Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
 Figure 67. Middle East & Africa mRNA Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
 Figure 68. Middle East & Africa mRNA Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
 Figure 69. Middle East & Africa mRNA Flu Vaccine Consumption Value Market Share by Country (2019-2030)
 Figure 70. Turkey mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 71. Egypt mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 72. Saudi Arabia mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 73. South Africa mRNA Flu Vaccine Consumption Value (2019-2030) & (USD Million)
 Figure 74. mRNA Flu Vaccine Market Drivers
 Figure 75. mRNA Flu Vaccine Market Restraints
 Figure 76. mRNA Flu Vaccine Market Trends
 Figure 77. Porters Five Forces Analysis
 Figure 78. Manufacturing Cost Structure Analysis of mRNA Flu Vaccine in 2023
 Figure 79. Manufacturing Process Analysis of mRNA Flu Vaccine
 Figure 80. mRNA Flu Vaccine Industrial Chain
 Figure 81. Sales Channel: Direct to End-User vs Distributors
 Figure 82. Direct Channel Pros & Cons
 Figure 83. Indirect Channel Pros & Cons
 Figure 84. Methodology
 Figure 85. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Moderna
BioNTech
CureVac
Novavax
Sanofi
Inovio Pharmaceuticals
Arcturus Therapeutics Holdings
eTheRNA immunotherapies
Valneva
Vaxart
Entos Pharmaceuticals
Abnova Corporation
Anima Biotech
Sarepta Therapeutics
iBio
Barinthus Biotherapeutics
Alnylam Pharmaceuticals
Beam Therapeutics

Related Reports

Global mRNA Flu Vaccine Supply, Demand and Key Producers, 2024-2030

Global mRNA Flu Vaccine Supply, Demand and Key Producers, 2024-2030

date 19 Apr 2024

date Pharma & Healthcare

The global mRNA Flu Vaccine market size is expected to reach $ million by 2030, rising at a market growth of %CAGR during the forecast period (2024-2030).

Product Tags

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>